The earnings call reflects a strong financial performance with record-breaking metrics and significant market share growth in key regions and product categories. However, there are challenges in maintaining market share in certain regions and managing cash flow effectively.

Company Guidance

During Cannara Biotech's Fiscal Year Q2 2025 earnings call, the company highlighted significant achievements and provided guidance for the future. Cannara reported record net revenues of CAD 26.6 million, marking a 6% increase quarter-over-quarter and a 35% rise year-over-year. The company also achieved a record gross profit before fair value adjustments of CAD 10.8 million, with a gross margin of 41%. Adjusted EBITDA was CAD 7.1 million, representing an 18% increase quarter-over-quarter and over 100% year-over-year growth, with an adjusted EBITDA margin of 27%. Cannara holds a 12.8% market share in Quebec, up from 9% the previous year, and is now the fastest-growing licensed producer in Canada by market share. The company plans to expand its cultivation capacity by nearly 20% to address increasing demand, especially with the upcoming vape market launch in Quebec. Cannara aims to leverage its competitive advantages in premium quality, scalability, and cost leadership to further drive growth and maintain strong financial performance.

Record-Breaking Financial Performance

Cannara achieved record revenue, gross profit, gross margin, operating income, and adjusted EBITDA in Q2 2025. Net revenues were CAD 26.6 million, up 6% quarter-over-quarter and 35% year-over-year. Adjusted EBITDA was CAD 7.1 million, up 18% quarter-over-quarter, representing over 100% year-over-year growth.

Strong Market Position in Quebec

Cannara holds a 12.8% market share in Quebec, up over 40% from the previous year. They are only 60 basis points from the number one spot, showing significant market share growth in their home province.

Leadership in Product Categories

Cannara leads the nationwide premium vape category with over 22% share and is the fastest-growing infused pre-roll multi-pack in Canada with a 10% market share. They have a commanding 73% share of infused pre-rolls in Quebec.

Cost Leadership and Operational Efficiency

Cannara maintains one of the lowest electricity rates in Canada, enabling cost-effective operations. They are expanding cultivation capacity by 20% with minimal capital outlay, showcasing strong operational efficiency.

Cannara Biotech (LOVFF) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

Daily Earnings Calendar >

LOVFF Earnings History

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change	Slides	Play Transcript
Dec 02, 2025	2025 (Q4)	- / -	0.046	―	―	―
Jul 28, 2025	2025 (Q3)	- / 0.03	0.016	81.82% (+0.01)	―
Apr 28, 2025	2025 (Q2)	- / 0.03	-0.028	197.37% (+0.05)	―
Jan 27, 2025	2025 (Q1)	- / 0.02	0.017	13.04% (<+0.01)	―	―
Nov 25, 2024	2024 (Q4)	- / 0.05	0.037	25.49% (<+0.01)	―	―
Jul 23, 2024	2024 (Q3)	- / 0.02	0.024	-33.33% (>-0.01)	―	―
Apr 29, 2024	2024 (Q2)	- / -0.03	-0.005	-442.86% (-0.02)	―	―
Jan 30, 2024	2024 (Q1)	- / -	0	―	―	―
Dec 07, 2023	2023 (Q4)	- / 0.02	0	―	―	―
Jul 26, 2023	2023 (Q3)	- / 0.02	0.012	106.25% (+0.01)	―	―

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed

LOVFF Earnings-Related Price Changes

Report Date	Price 1 Day Before	Price 1 Day After	Percentage Change
Jul 28, 2025	$1.30	$1.32	+1.54%
Apr 28, 2025	$1.01	$1.01	0.00%
Jan 27, 2025	$0.60	$0.66	+10.00%
Nov 25, 2024	$0.45	$0.52	+15.56%

Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does Cannara Biotech (LOVFF) report earnings?

Cannara Biotech (LOVFF) is schdueled to report earning on Dec 02, 2025, Before Open (Confirmed).

What is Cannara Biotech (LOVFF) earnings time?

Cannara Biotech (LOVFF) earnings time is at Dec 02, 2025, Before Open (Confirmed).

Where can I see when companies are reporting earnings?

You can see which companies are reporting today on our designated earnings calendar.

What companies are reporting earnings today?

You can see a list of the companies which are reporting today on TipRanks earnings calendar.

What is LOVFF EPS forecast?

Currently, no data Available

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing